Research and development

Companies work to make new things.

They might make a new tool or a new toy. This is called research and development. It is a way to find new ideas.

This work is very hard. People do not always know if it will work. This makes it a big risk. They might spend much money and fail.

Some groups spend a lot of money on this. They want to make things that people need. This helps a company stay strong.

Big companies use special teams for this. They might even work with schools. This helps them find the best ideas.

New ideas help the whole world change. It is how we get better things.

Companies want to make new things. This work is called research and development. We call this R&D for short.

It is a way to find new ideas. R&D is the first step in making a new product. It can also be a new way to make things.

Doing R&D is very hard. Researchers do not always know how to get the result they want. This makes it a big risk. A project might fail and leave nothing behind. Because of this, R&D does not always make money right away.

Some groups spend a lot of money on R&D. This is called R&D intensity. It shows how much money a firm spends on new ideas. High-tech firms spend a lot. A biotech company like Allergan spends 43.4% of its money on R&D. Most industrial companies spend about 40% of their revenue on other things. R&D helps companies stay strong. It helps them meet the needs of people.

Research and development, often called R&D, is the work used to create new products or services.

It is the very first stage in making something new. This work can be done by big companies, wealthy individuals, or even governments. The main goal is to find better ways to do things or invent new tools. R&D is different from most business work because it does not always make money right away. It is often a risky path with no guarantee of success.

How does this work in the real world? Sometimes, a company looks at what customers need through market research. If they want to lead with new technology, they use R&D to meet those unmet needs. Specialized units or even universities often do this work. Researchers try to find new ways to use advanced tools like special software or mechanical parts. They might even reuse old manufacturing processes to save money. This step-by-step path helps turn a tiny idea into a real product.

History shows that different places use R&D in different ways. In the United States, private businesses have funded more R&D since the 1960s. For example, in 2020, the U.S. federal budget for R&D was $156 billion. A large part of that, 41.4%, went to the Department of Defense. Israel is also a leader in this field. In the 1980s, Israel passed laws to help the commercial sector invest in new ideas. This helped create a famous high-tech area called Silicon Wadi.

We can measure how much a company cares about new ideas using a number called R&D intensity. This is the amount of money spent on R&D compared to how much money the company makes. A typical industrial company might spend about 3.5% of its revenue. However, high-tech companies spend much more. A computer company might spend 7% of its money. Large medicine companies like Merck & Co. spend 14.1%. The biotech company Allergan spends a huge 43.4% on R&D.

Understanding R&D helps you see how the world around you changes. Every new gadget or medicine likely started as an R&D project. It is like a scientist trying a new experiment to see if it works. Even though many projects fail, the ones that succeed can change everything. High-tech firms often use these successes to become very productive. This cycle of trying, failing, and succeeding is what drives progress in our modern world.

Research and development, often called R&D, is the set of innovative activities used to create new products or services.

This process serves as the essential first stage in developing a potential new service or a new production process. R&D is conducted by various entities, including large corporations, wealthy industrialists, or national governments. Unlike most standard business operations, R&D is not intended to yield immediate profit. Instead, it is a long-term, future-oriented activity focused on science and technology. Because the results are not guaranteed, R&D carries significant risk and an uncertain return on investment.

The mechanism of R&D often begins with identifying a specific need. Some companies use a marketing-driven system that starts with market research. This research establishes what consumers need and identifies potential niche markets. If a company is technology-driven, R&D is directed toward solving unmet technical needs.

Once a goal is set, specialized units or centers within a company perform the work. These activities can also be outsourced to universities, state agencies, or contract research organizations. Researchers often attempt to repurpose advanced technologies to manage high overhead costs. They might reuse expensive safety certifications, specialized embedded software, or mechanical subsystems to build something new.

Companies can be categorized by their level of investment in these activities. We measure this using a metric called R&D intensity, which is the ratio of R&D spending to total revenue. A typical industrial company might have an R&D intensity of about 3.5%. High-technology companies, such as computer manufacturers, often spend around 7% of their revenue. Pharmaceutical companies spend even more, such as Merck & Co. at 14.1% or Novartis at 15.1%. Some companies are considered remarkable for their extreme spending. For example, the engineering company Ericsson spends 24.9%, while the biotech company Allergan invests 43.4% of its revenue.

High-tech companies that invest heavily in R&D often face unique economic realities. Because many individual projects yield no usable product, these firms face a high risk of failure. To compensate for this risk, they often aim for very high gross margins. These margins can range from 60% to 90% of revenues. In these cases, manufacturing might cost only 10% of the final product price. This high-profit model is necessary because the cost of failed experiments is so high. Such companies usually thrive in markets with extreme high-technology needs, such as aeronautics, military weapons, or specialized prescription drugs.

History shows how different nations have shaped their R&D landscapes. In the United States, private businesses have provided an increasing share of R&D funding since the 1960s. For example, the U.S. federal research and development budget for fiscal year 2020 was $156 billion. Of that amount, 41.4% was designated for the Department of Defense.

Israel has also become a global leader in this field. In the 1980s, Israel passed laws to encourage the commercial sector to invest in R&D. This helped create the "Silicon Wadi," a high-tech cluster of startups. By 2023, this ecosystem was ranked as the fourth leading startup ecosystem in the world.

There is a strong connection between R&D and a company's productivity. Research by Francesco Crespi and Cristiano Antonelli found a positive correlation between R&D and productivity across all sectors. However, this link is much stronger in high-tech firms than in low-tech firms. High-tech firms often experience "virtuous" Matthew effects, where they receive subsidies based on merit. In contrast, low-tech firms sometimes experience "vicious" Matthew effects, receiving subsidies based on name recognition. Despite this, even low-tech R&D can have carryover effects that benefit other parts of the marketplace.

Despite the potential for growth, R&D management is a difficult discipline. One major challenge is that researchers do not know in advance exactly how to achieve a desired result. This means that higher spending does not always guarantee more creativity or higher profits. There are also two main types of risk. The first is the nature of the research itself, where a project might fail without leaving any value behind. The second is takeover risk, where other companies might try to buy a firm just to acquire its technologies.

On a global scale, R&D is a key part of international development goals. In 2015, R&D made up an average of 2.2% of the global GDP. By 2018, this average had shifted to 1.79%. Many countries have agreed to monitor their research intensity and researcher density to reach Sustainable Development Goals by 2030. While the European Union has faced challenges in meeting its 3% GDP target for R&D, it continues to support innovation through programs like Horizon 2020. These efforts aim to find safe and economically feasible solutions for human activities across the globe.